As miR-29b has been shown to directly target DNMT3A and 3B and indirectly down-regulate DNMT1 by targeting Sp1 [34], miR-29b induction might participate in OF-mediated inhibition of DNMTs in MG cells. The gene discussed is DNMT1; the disease is myasthenia gravis.